§ 36-2907.15 — Opioid use disorder treatment; standards; centers of excellence; annual report

Arizona § 36-2907.15

• Jurisdiction: Arizona
• Title 36: Arizona Revised Statutes
• Ch. 29: ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM ADMINISTRATION
• Art. 1: Arizona Health Care Cost Containment System

Text

A. On or before December 31, 2019, the administration and the department of health services shall establish standards for designating centers of excellence for treating opioid use disorder statewide. The director of the Arizona health care cost containment system shall publish the draft standards on the administration's public website and hold at least two public hearings to receive input before implementing the standards. The administration shall publish the final standards for designating centers of excellence for treating opioid use disorder on its public website.

B. At a minimum, the standards established pursuant to subsection A of this section shall include:

1. Information regarding opioid treatment program providers and facilities.

2. Information regarding office-based opioid agonist treatment providers.

3. Parameters to ensure coordination of care that includes behavioral health, physical health and medication-assisted treatment for opioid use disorder.

4. Tracking and reporting requirements that identify:

(a) Treatment capacity.

(b) Quantitative metrics related to quality of care and patient outcomes.

(c) Qualitative metrics related to patient satisfaction.

5. An annual evaluation by a third-party auditor of the accuracy and completeness of data provided by the centers of excellence.

C. The administration shall establish a statewide learning collaborative to share best practices and establish peer-to-peer support between centers of excellence.

D. The administration shall maintain an accurate list of designated centers of excellence, including contact information, on its website.

E. Designated centers of excellence shall:

1. Increase capacity for treating opioid use disorder in opioid treatment programs and office-based opioid agonist treatment statewide.

2. Demonstrate effective delivery of medication-assisted treatment for opioid use disorder using evidence-based practices as defined by the substance abuse and mental health services administration, a federally designated accreditation agency for rehabilitation facilities and the administration.

3. Comply with all tracking, reporting and evaluation requirements.

4. Participate in the statewide learning collaborative.

F. On or before January 15 of each year, the administration shall submit a report to the governor, the president of the senate and the speaker of the house of representatives, and shall provide a copy to the secretary of state, outlining:

1. The standards for designating centers of excellence.

2. The statewide list of designated centers of excellence.

3. A summary of the performance of the centers of excellence.